Table 1.
Clinical Characteristics of UC Patients
| Characteristics | Value (n = 33) |
|---|---|
| Age (yr) | 29 (23–48) |
| Male sex | 18 (53) |
| Disease duration (yr) | 3 (1–8) |
| Extent of the disease | |
| E2 (left-sided UC) | 5 (15) |
| E3 (extensive UC) | 28 (85) |
| Concurrent medications | |
| Prednisolone | 14 (42) |
| Dose of prednisolone (mg) | 6.3 (5.0–18.8) |
| Anti-TNF-α agents | 12 (36) |
| Cyclosporine | 1 (3) |
| 5-ASA | 26 (79) |
| Thiopurine | 18 (55) |
| CAI score | 8 (8–11) |
| MES | 2 (2–3) |
| CRP (mg/L) | 3.0 (1.4–8.9) |
Values are presented as median (interquartile range) or number (%).
UC, ulcerative colitis; TNF, tumor necrosis factor; 5-ASA, 5-aminosalicylic acid; CAI, clinical activity index (Rachmilewitz index); MES, Mayo endoscopic subscore; CRP, C-reactive protein.